PODD Jan 2025 100.000 call
| Previous close | 77.80 |
| Open | 77.80 |
| Bid | 104.50 |
| Ask | 113.00 |
| Strike | 100.00 |
| Expiry date | 2025-01-17 |
| Day's range | 77.80 - 77.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
GuruFocus.comInsider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)
Insulet Corp, headquartered in Acton, Massachusetts, is a medical device company primarily engaged in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes. Over the past year, Timothy Scannell has sold a total of 15,300 shares of Insulet Corp and has not made any purchases of the stock. Shares of Insulet Corp were trading at $225.84 on the day of the sale.
Insider MonkeyInsulet’s (PODD) Sales And Margins Surpassed Expectations
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The Mid Company Fund (Institutional shares) returned -7.85 % in the quarter significantly underperforming -3.21% return for the Russell Midcap Growth Index. The strategy focuses […]
ZacksShould You Continue to Retain PODD Stock in Your Portfolio Now?
Insulet's Omnipod 5 is set to drive growth in the upcoming quarters. Meanwhile, the stock is facing challenges due to economic uncertainties.
